Does the guidance method affect the doses of botulinum toxin in writer's cramp?
- 8 February 2024
- journal article
- research article
- Published by Elsevier in Revue Neurologique
- Vol. 180 (6) , 548-558
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Long‐term follow‐up of botulinum toxin therapy for focal hand dystonia: Outcome at 10 years or moreMovement Disorders, 2011
- Comparison of Surface and Ultrasound Localization to Identify Forearm Flexor Muscles for Botulinum Toxin InjectionsPM&R, 2010
- Clinical profile of various sub-types of writer's crampParkinsonism & Related Disorders, 2007
- Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-upJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxinJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Botulinum toxin in writer's cramp: objective response evaluation in 31 patients.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Botulinum Toxin in the Treatment of Writer's CrampClinical Neuropharmacology, 1996
- Double‐Blind trial of botulinum toxin for treatment of focal hand dystoniaMovement Disorders, 1995
- Treatment of focal dystonias of the hand with botulinum toxin injections.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Epidemiology of focal and generalized dystonia in Rochester, MinnesotaMovement Disorders, 1988